Jingyang J. Wu

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients

Sunwen Chou, Sophie Alain, Carlos Cervera et al. · The Journal of Infectious Diseases · 2023 · 77 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients

Johan Maertens, Catherine Cordonnier, Péter Jaksch et al. · Open Forum Infectious Diseases · 2016 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Maribavir for Treatment of Cytomegalovirus (CMV) Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant (SCT) or Solid Organ Transplant (SOT) Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study

Genovefa A. Papanicolaou, Fernanda P. Silveira, Amelia Langston et al. · Open Forum Infectious Diseases · 2016 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17